Left Main Artery Disease
High-sensitivity cardiac troponin may not exclude myocardial ischemia
Very low concentrations of high-sensitivity cardiac troponin did not allow the safe exclusion of inducible myocardial ischemia, according to a study published in the Annals of Internal Medicine.
EXCEL trial leadership responds to claims of improper conduct
Editor’s Note: The following is a response written by the EXCEL trial leadership to claims of improper conduct of the trial, as outlined in a Healio article posted on Dec. 12, 2019. The EXCEL trial leadership response was issued on Dec. 12. Healio is posting the response in its entirety at the request of the authors.
Societies at odds over PCI for left main disease; questions of trial conduct draw response
The European Association for Cardio-Thoracic Surgery has withdrawn its support for the left main disease recommendations of the 2018 European Association for Cardio-Thoracic Surgery/European Society of Cardiology Clinical Guidelines for Myocardial Revascularization, but a portion of the association’s explanation has drawn criticism from the Society for Cardiovascular Angiography and Interventions.
EXCEL: PCI ‘acceptable revascularization modality’ for left main CAD at 5 years
SAN FRANCISCO — Final 5-year data from the EXCEL trial demonstrate similar rates of death, stroke or MI with PCI or CABG for treatment of patients with left main CAD, according to late-breaking data presented at TCT 2019.